PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Gedeon Richter Signs an Asset Purchase Agreement with Mycenax for Biosimilar Tocilizumab to Treat Rheumatoid Arthritis

Gedeon Richter Signs an Asset Purchase Agreement with Mycenax for Biosimilar Tocilizumab to Treat Rheumatoid Arthritis

April 29, 2020

Sarepta Signs a Research Agreement with the US Department of Defense to Identify Antisense Oligonucleotides Against COVID-19

Sarepta Signs a Research Agreement with the US Department of Defense to Identify Antisense Oligonucleotides Against COVID-19

April 29, 2020

Novartis' Cosentyx (secukinumab) Receives EC's Approval for Axial Spondyloarthritis Spectrum Marking its Fourth Indication in EU

Novartis' Cosentyx (secukinumab) Receives EC's Approval for Axial Spondyloarthritis Spectrum Marking its Fourth Indication in EU

April 29, 2020

BioNTech and Pfizer Complete Dosing of BNT162 in First Cohort of P-I/II Study in Germany

BioNTech and Pfizer Complete Dosing of BNT162 in First Cohort of P-I/II Study in Germany

April 29, 2020

Astellas Signs a Three-Year Research Alliance with Harvard University Across Multiple Therapeutic Areas

Astellas Signs a Three-Year Research Alliance with Harvard University Across Multiple Therapeutic Areas

April 29, 2020

Novartis Plans to Commence P-III Clinical Study Evaluating Canakinumab for Patients with COVID-19 Pneumonia

Novartis Plans to Commence P-III Clinical Study Evaluating Canakinumab for Patients with COVID-19 Pneumonia

April 29, 2020

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us